Evidence map›Paper›PMID 19806284›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2010

Hip protectors: recommendations for conducting clinical trials--an international consensus statement (part II).

I D Cameron, S Robinovitch, S Birge, P Kannus, K Khan, J Lauritzen, J Howland, S Evans, J Minns, A Laing and 4 more

Abstract readConsensus Statement
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Pooled it
  3. Hip protectors for preventing hip fractures in older people.The Cochrane database of systematic reviews · 2014
    Pooled it
  4. Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Pooled it
  5. Pooled it
  6. Increasing adherence with the use of hip protectors for older people living in the community.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Trial
  7. Review
  8. Review
  9. Potential Solutions for the Mitigation of Hip Injuries Caused by Falls in Older Adults: A Narrative Review.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Review
  10. Article
  11. Biomechanical testing of hip protectors following the Canadian Standards Association express document.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Article
  12. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
    Article
  13. Autonomy, choice, patient-centered care, and hip protectors: the experience of residents and staff in long-term care.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2014
    Article
  14. Article
  15. Availability and use of hip protectors in residents of nursing homes.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Article
  16. Emergency orthogeriatrics: concepts and therapeutic alternatives.Emergency medicine clinics of North America · 2010
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

I D CameronRehabilitation Studies Unit, University of Sydney, Sydney, New South Wales, Australia. ianc@mail.usyd.edu.au
S Robinovitch
S Birge
P Kannus
K Khan
J Lauritzen
J Howland
S Evans
J Minns
A Laing
P Cripton
S Derler
D Plant
D P Kiel

Funding

Trochanteric Padding to Prevent Hip FracturesR01AG018461 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI KIEL, DOUGLAS P. · 2001 to 2005
$8.6M
CIHRNIA NIH HHS R01 AG018461NIA NIH HHS R01 AG18461
6 · The paper itself

Abstract

introductionWhile hip protectors are effective in some clinical trials, many, including all in community settings, have been unable to demonstrate effectiveness. This is due partly to differences in the design and analysis. The aim of this report is to develop recommendations for subsequent clinical research.

methodsIn November of 2007, the International Hip Protector Research Group met to address barriers to the clinical effectiveness of hip protectors. This paper represents a consensus statement from the group on recommended methods for conducting future clinical trials of hip protectors. RESULTS AND

conclusionsConsensus recommendations include the following: the use of a hip protector that has undergone adequate biomechanical testing, the use of sham hip protectors, the conduct of clinical trials in populations with annual hip fracture incidence of at least 3%, a run-in period with demonstration of adequate adherence, surveillance of falls and adherence, and the inclusion of economic analyses. Larger and more costly clinical trials are required to definitively investigate effectiveness of hip protectors.

Indexed as

Protective DevicesAccidental FallsHip FracturesHumansRandomized Controlled Trials as TopicResearch DesignTreatment Outcome

Identifiers

PMID19806284
PMCPMC5407461

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.